The industry is expected to grow significantly over the next few years as healthcare accessibility improves and insurance penetration increases
These data support clinically meaningful efficacy within this patient population. We observed a high rate of complete responses in patients with laCSCC
The event is expected to attract more than 100 senior professionals from pharmaceutical companies, CROs, regulatory agencies, and technology organisations
Access to genomic testing, not therapy cost, is the biggest challenge
We are building an AI-native operating system for pharma sales and distribution
Industry veteran to lead Brinton’s expansion across India and key Asia Pacific markets
Lormalzi is the first and only once-monthly amyloid plaque-targeting therapy with clinical evidence
Investment will support LifeSigns’ global expansion across Southeast Asia and GCC markets
Mumbai event on June 24–25 will spotlight real-world impact of pharmacovigilance beyond AI adoption
Diagnostic major processes 59 million tests in Q4FY26 as revenue rises 20% and specialty testing portfolio expands
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
